Rumors have circulated that Swiss-based drugmakers Roche and Novartis, leaders in the cancer field, and Pfizer are actively looking at a buyou​t of Bristol-Myers Squibb.

Would BMS really become a Big Biopharma takeover target? It has plenty of ‘solid products’ to recommend it, and overseas cash might soon come back to the U.S. to fuel big deals, analysts say.